Ten kHz spinal cord stimulation for the treatment of chronic peripheral polyneuropathy: 12-Month results from prospective open-label pilot study

被引:7
|
作者
Galan, Vincent [1 ]
Scowcroft, James [2 ]
Chang, Paul [1 ]
Li, Sean [3 ]
Staats, Peter [3 ]
Subbaroyan, Jeyakumar [4 ]
Caraway, David [4 ]
机构
[1] Georgia Pain Care, 1365 Rock Quarry Rd,Suite 202, Stockbridge, GA 30281 USA
[2] KC Pain Ctr, Lees Summit, MO USA
[3] Premier Pain Ctr, Shrewsbury, NJ USA
[4] Nevro Corp, Redwood City, CA USA
关键词
10 kHz SCS; chronic peripheral polyneuropathy; visual analog scale; QUALITY-OF-LIFE; 10-KHZ HIGH-FREQUENCY; CHRONIC PAIN; CHRONIC BACK; NEUROPATHY; OUTCOMES; EFFICACY; LIMB; SCS; MULTICENTER;
D O I
10.1111/papr.13059
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background The goal of this study was to demonstrate that the paresthesia-independent 10 kHz spinal cord stimulation (SCS) can provide long-term pain relief in patients with peripheral polyneuropathy (PPN). Clinically diagnosed subjects with PPN refractory to conventional medical management were enrolled in this prospective, multicenter study between November 2015 and August 2016, after institutional review board approval and patient informed consent were obtained. Methods Subjects underwent trial stimulation utilizing 2 epidural leads, and if successful, were implanted with a permanent 10 kHz SCS system and followed up for 12 months post-implant. Outcome measures included adverse events, pain, neurological assessments, disability, function, quality of life, pain interference, sleep, satisfaction, and global impression of change. Data are presented as descriptive statistics. Permanent implant population results are reported as mean +/- standard error. Results Twenty-one of the 26 trialed subjects had a successful trial and 18 received a permanent implant. All subjects had the leads placed anatomically without the need for paresthesia. Subjects experienced significant and sustained pain relief (at least 65% at all timepoints) whereas physicians noted improvements in neurological function. Significant improvements in disability, function, sleep, sensory, and affective dimensions of pain were reported at all timepoints. All adverse events were resolved without sequelae. Conclusion Findings from this study suggest that 10 kHz SCS may provide sustained pain relief and disability improvements in patients suffering from PPN.
引用
收藏
页码:898 / 906
页数:9
相关论文
共 50 条
  • [41] Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
    Greg W. Mattingly
    Peter M. Haddad
    Michael Tocco
    Jane Xu
    Debra Phillips
    Andrei Pikalov
    Antony Loebel
    [J]. BMC Psychiatry, 20
  • [42] An Open-Label Pilot Study Investigating Noninvasive High-Frequency Peripheral Nerve Fiber Stimulation in Chronic Pain
    Hegarty, Dominic A.
    Bretherton, Beatrice
    [J]. PAIN PRACTICE, 2021, 21 (05) : 578 - 587
  • [43] Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
    Mattingly, Greg W.
    Haddad, Peter M.
    Tocco, Michael
    Xu, Jane
    Phillips, Debra
    Pikalov, Andrei
    Loebel, Antony
    [J]. BMC PSYCHIATRY, 2020, 20 (01)
  • [44] Evaluation of the Effectiveness of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Chronic Low Back Pain Due to Severe Lumbar Spinal Degeneration: A 12-Month, Open-Label, Prospective Controlled Trial
    Atluri, Sairam
    Murphy, Matthew B.
    Dragella, Ryan
    Herrera, Jessica
    Boachie-Adjei, Kwadwo
    Bhati, Sachi
    Manocha, Vivek
    Boddu, Navneet
    Yerramsetty, Pavan
    Syed, Zaid
    Ganjam, Meghana
    Jain, Divit
    Syed, Zaynab
    Grandhi, Nikhil
    Manchikanti, Laxmaiah
    [J]. PAIN PHYSICIAN, 2022, 25 (02) : 193 - 207
  • [45] Safety and efficacy of cervical 10 kHz cervical spinal cord stimulation (SCS) for the management of refractory chronic migraine: a prospective, proof-of-concept open label study
    Giorgio, Lambru
    Adnan, Al-Kaisy
    Stefano, Palmisani
    Roy, Carganillo
    Samuel, Wesley
    David, Pang
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [46] A Prospective, Open-Label, Multicenter Study to Assess the Efficacy of Spinal Cord Stimulation and Identify Patients Who Would Benefit COMMENTS
    Navalgund, Yeshvant
    Yamamoto, Takamitsu
    [J]. NEUROMODULATION, 2012, 15 (01): : 12 - 12
  • [47] Treatment of chronic tinnitus with repeated sessions of prefrontal transcranial direct current stimulation: outcomes from an open-label pilot study
    Frank, Elmar
    Schecklmann, Martin
    Landgrebe, Michael
    Burger, Julia
    Kreuzer, Peter
    Poeppl, Timm B.
    Kleinjung, Tobias
    Hajak, Goran
    Langguth, Berthold
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (02) : 327 - 333
  • [48] Treatment of chronic tinnitus with repeated sessions of prefrontal transcranial direct current stimulation: outcomes from an open-label pilot study
    Elmar Frank
    Martin Schecklmann
    Michael Landgrebe
    Julia Burger
    Peter Kreuzer
    Timm B. Poeppl
    Tobias Kleinjung
    Göran Hajak
    Berthold Langguth
    [J]. Journal of Neurology, 2012, 259 : 327 - 333
  • [49] DEGARELIX VERSUS LEUPROLIDE DEPOT (7.5 MG): RESULTS FROM A 12-MONTH, RANDOMIZED, OPEN-LABEL, PHASE III STUDY IN PATIENTS WITH PROSTATE CANCER
    Persson, B. E.
    Boccon-Gibod, L.
    Klotz, L.
    Schroder, F. H.
    Andreou, C.
    Cantor, P.
    Jensen, J. K.
    Olesen, T. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S318 - S318
  • [50] Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
    Torres, Dawn M.
    Jones, Frances J.
    Shaw, Janet C.
    Williams, Christopher D.
    Ward, John A.
    Harrison, Stephen A.
    [J]. HEPATOLOGY, 2011, 54 (05) : 1631 - 1639